DERMATOLOGICALS IN SLOVENIA

Euromonitor International

January 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Dermatologicals Recovers Across Product Categories

Internet Retailing To Fuel Growth Over the Forecast Period

Increased Competition and Consumer Perception To Hinder Future Growth

Competitive Landscape

Dermatologicals Remains Calm on the Surface

Recognisable Brand Names Lead

Competition Intensifying Although at A Modest Pace

Category Data

Table 1 Sales of Dermatologicals by Category: Value 2013-2018

Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Table 5 Forecast Sales of Dermatologicals by Category: Value 2018-2023

Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Executive Summary

Consumer Health Emerges From A Volatile Period, Although Still Not on Stable Ground

Higher Sales Levels Potentially Fuelled by Government Cuts To the Healthcare Budget

Little Change Other Than Increasing Competition

Distribution Channels Limited by Legislation for Most Categories

the Forecast Period Sees A Green Light for OTC Sales

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 8 Life Expectancy at Birth 2013-2018

Market Data

Table 9 Sales of Consumer Health by Category: Value 2013-2018

Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 13 Penetration of Private Label by Category: % Value 2013-2018

Table 14 Distribution of Consumer Health by Format: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format and Category: % Value 2018

Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Definitions

Sources

Summary 1 Research Sources

Dermatologicals recorded a rather modest performance overall in 2018, with different growth rates within specific categories, with a slow recovery from the earlier review period in terms of value sales as a result of declining unit prices. Some categories, however, witnessed marginal declines in retail volume sales. Hair loss treatments and vaginal antifungals recorded the strongest growth, in that order, both in terms of retail value and volume, mainly due to the effects of marketing on the pot...

Euromonitor International's Dermatologicals in Slovenia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.